Public health, innovation, intellectual property and trade

Antimicrobial Resistance: How to Foster Innovation, Access and Appropriate Use of Antibiotics? A Joint Technical Symposium by WHO, WIPO and WTO

Antimicrobial resistance is one of the most pressing challenges for humanity. It affects all areas of health, involves many sectors and has an impact on the whole of society. Increasing resistance threatens to roll back the achievements of modern medicine as many medicinal procedures rely on effective antibiotics. Antibiotics, more than other medicines, can be considered a public good for which society has a collective responsibility. The Symposium will offer a forum to exchange views and experiences, to achieve a better understanding of the global challenge of antimicrobial resistance and to envisage possible ways forward.
Date: 25 October 2016
Place: WIPO Headquarters, Geneva, Switzerland

UN Secretary-General’s High-Level Panel on Access to Medicines

In November 2015, UN Secretary-General Ban Ki-Moon convened a High-Level panel to find solutions to increase access to medicines. On request of the Panel, WHO has provided a general submission as part of the consultation process to support the work of the Panel. This submission briefly presents some relevant WHO experience in access to medicines, cooperation between international agencies, and a number of projects WHO is currently implementing to foster the development of health products that address priority health needs.

Consultation on options for establishing a global development and stewardship framework

The WHO holds a consultation on options for establishing a global development and stewardship framework to fight antimicrobial resistance on 29 February 2016. The consultation is held in response to resolution WHA68.7 that endorsed the Global action plan on antimicrobial resistance and will be open to Member States, non-governmental organizations in official relations with WHO and intergovernmental organizations.

Global survey for Priority Assistive Products List (APL)


WHO has launched a survey to identify the 50 top technologies people need worldwide to improve their lives. The survey, issued in the world’s 50 most spoken languages, will use the information gathered to build the WHO Priority Assistive Products List (APL), a tool that will set the standard for the most essential assistive products that must be available in a health system.




Public health, innovation, intellectual property and trade

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)